Main logo

Main

Verified

Insilico Medicine's Pharma.ai is a suite of generative AI software tools used for drug discovery, scientific research, and sustainability work. It includes modules for target discovery (PandaOmics), molecule generation (Chemistry42), biologics design (Generative Biologics), clinical trial prediction (inClinico), and a multi-agent research assistant (DORA), among others. The platform is aimed at pharmaceutical companies, biotech researchers, and scientists working on drug discovery pipelines, from early target identification through clinical trial stages. Insilico also runs its own therapeutic pipeline using these tools, with several programs out-licensed to pharma partners. The site offers a free course on disease modeling and target discovery, and lists free and paid plan options.

Visit Official Website

Main at a glance

What it is
Insilico Medicine's Pharma.
Who it's for
Most useful for anyone who needs results in the AI Healthcare, Wellness & Medical area without a specialist on staff.
Primary use case
Generative AI and Automation for Longevity and Sustainability.
  • CategoryAI Healthcare, Wellness & Medical
  • PricingFree Tier
  • Starting priceFree, paid plans available
  • Credit cardNo credit card required
  • Foundation modelFine-tuned
  • Bring your own keyNot supported
  • RatingNo reviews yet. Be the first to rate.

Video Spot

No creator video yet. “Stop Getting Lost in the AI Labyrinth” — the official Zoipi platform showcase.

Overview

Insilico Medicine's Pharma.ai is a suite of generative AI software tools used for drug discovery, scientific research, and sustainability work. It includes modules for target discovery (PandaOmics), molecule generation (Chemistry42), biologics design (Generative Biologics), clinical trial prediction (inClinico), and a multi-agent research assistant (DORA), among others. The platform is aimed at pharmaceutical companies, biotech researchers, and scientists working on drug discovery pipelines, from early target identification through clinical trial stages. Insilico also runs its own therapeutic pipeline using these tools, with several programs out-licensed to pharma partners. The site offers a free course on disease modeling and target discovery, and lists free and paid plan options.

Generative AI and Automation for Longevity and Sustainability

In detail

Insilico Medicine offers Pharma.ai, a suite of generative AI tools built for drug discovery, scientific research, and environmental sustainability work. The suite covers multiple stages of the drug development process, including target identification, molecule generation, biologics optimization, lab automation, and clinical trial design and prediction.

The tools are intended for pharmaceutical companies, biotech firms, and researchers working across the drug discovery and development pipeline, from early-stage target discovery through to later clinical phases. Individual modules include PandaOmics for target discovery, Chemistry42 for generative chemistry, Generative Biologics for biomolecule design, inClinico for clinical trial prediction, and DORA, a multi-agent generative research assistant. There are also specialized components such as ADMET and off-target prediction, a retrosynthesis tool, and model training capabilities.

Insilico also runs foundation models under the Nach01 and Precious GPT names for multimodal biological and chemical data, and a benchmarking initiative called MMAI Gym that evaluates model performance across drug discovery tasks. The company applies these tools to its own therapeutic pipeline, with programs spanning target identification through clinical trials, several of which have been out-licensed to pharmaceutical partners such as Exelixis and Menarini.

What differentiates this offering is the breadth of the suite: rather than a single point tool, it spans the full drug discovery and development workflow, combined with Insilico's own track record of advancing internally discovered programs into licensing deals. The listing indicates a freemium pricing model, with a free tier and paid plans available, though specific pricing details are not stated on the page. The site also offers a free course on disease modeling and target discovery for those wanting to learn the underlying concepts.

Common uses

  • Explore AI applications for longevity-focused initiatives
  • Assess automation opportunities in wellness workflows
  • Evaluate generative AI for sustainability projects
  • Consider AI support for long-term health research

Pros

  • Explicit focus on longevity and sustainability
  • Combines generative AI with automation
  • Relevant themes for healthcare and wellness teams

Cons

  • Specific features and workflows are not described
  • Clinical validation and medical suitability are unspecified
  • Data privacy and integration details are not provided

Generated from the listing's details and not yet checked by a Zoipi editor.

Key Features

  • Insilico Medicine's Pharma.ai is a suite of generative AI software tools used for drug discovery, scientific research, and sustainability work
  • Insilico also runs its own therapeutic pipeline using these tools, with several programs out-licensed to pharma partners
  • The site offers a free course on disease modeling and target discovery, and lists free and paid plan options

Best For

  • People who spend real hours each week on ai healthcare, wellness & medical
  • Anyone testing the space without an upfront budget
  • Buyers who want a highly rated, well-established option

Pricing Model

Free Tier. Generous ongoing free tier you can start with, no credit card needed. Paid plans unlock higher limits.

Pricing Breakdown

Starting price
Free, paid plans available
Free trial / credits
Ongoing free tier, no time limit
Credit card
No credit card required
Freemium

Screenshots

Live preview of Main's website.

Frequently asked questions

It is listed as freemium, offering a free tier along with paid plans.

Community Reviews & Discussion

0 reviews · replies are moderated before they appear.

  • No reviews yet — be the first to review Main.